CellVec seeks to advance clinical gene therapy through the innovative development and manufacturing of viral gene delivery vectors.
To ensure patient safety and fitness for purpose, we are committed to maintaining quality and regulatory compliance to rigorous standards (FDA and EU), while supporting our clients through commercial supply and licensing of their products. Our scientists are leading subject-matter experts and active participants in governmental advisory groups.
The CellVec team is made up of individuals experienced in a broad range of disciplines including:
Vector construct design
Commercial operations
Quality control
GMP manufacturing of vectors
Process development
Quality assurance
Supply chain management
